← ANALYST RATINGS · TIPRANKS
Elevance Health (ELV): analyst forecast and price target
Analyst consensus
Strong Buy6 Buy2 Hold0 Sell
Ratings of 8 analysts in the last 3 months12-month forecast
Based on 8 price targets given in the last 3 months, the average target is $465, the highest $488, the lowest $424. The average is +8.5% from the last price of $428.
Analyst ratings 25
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% | Guggenheim | $455 → $460+1.1% | Buy | +7.4% | Reiterated | 12.10.26on TipRanks 07:20 | +2.3%next day +0.8% | ↗ |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $424 | Hold | −1.0% | Reiterated | 07.10.26on TipRanks Oct 8 21:45 | +1.3%next day −0.4% · 5 days +6.9% | ↗ |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $457 → $469+2.6% | Buy | +9.5% | Reiterated | 07.10.26on TipRanks 03:55 | +1.3%next day −0.4% · 5 days +6.9% | ↗ |
| Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% | Bernstein | $488 | Buy | +13.9% | Reiterated | 05.10.26on TipRanks 07:30 | +1.4%next day +0.9% · 5 days +6.6% | ↗ |
| A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% | UBS | $460 | Buy | +7.4% | Reiterated | 18.09.26on TipRanks 06:45 | −0.9%next day −1.9% · 5 days −4.9% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $473 | Buy | +10.4% | Reiterated | 15.09.26on TipRanks 07:45 | −1.1%next day −0.8% · 5 days −6.0% | ↗ |
| Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% | Bank of America Securities | $460 → $480+4.3% | Buy | +12.1% | Reiterated | 11.09.26on TipRanks 09:36 | −0.3%next day +1.8% · 5 days −1.8% | ↗ |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $457 | Buy | +6.7% | Reiterated | 11.09.26on TipRanks 05:15 | −0.3%next day +1.8% · 5 days −1.8% | ↗ |
| AI PerPlexity Medical - Healthcare PlansPerPlexity SonarPro | TipRanks - PerPlexity | $443 → $439−0.9% | Buy | +2.5% | Reiterated | 10.09.26on TipRanks 14:05 | — | |
| AI xAi Medical - Healthcare PlansxAI Grok-4 | TipRanks - xAI | $437 → $445+1.8% | Buy | +3.9% | Reiterated | 10.09.26on TipRanks 13:05 | — | |
| AI DeepSeek Medical - Healthcare PlansDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $406 → $419+3.2% | Hold | −2.2% | Reiterated | 10.09.26on TipRanks 13:05 | — | |
| AI OpenAI Medical - Healthcare PlansOpenAI 5.2 | TipRanks - OpenAI | $425 → $437+2.8% | Buy | +2.0% | Upgrade | 10.09.26on TipRanks 13:05 | — | |
| AI Anthropic Medical - Healthcare PlansAnthropic Opus-4.6 | TipRanks - Anthropic | $396 → $411+3.8% | Hold | −4.0% | Reiterated | 10.09.26on TipRanks 13:05 | — | |
| AI Google Medical - Healthcare PlansGemini 3.1Pro | TipRanks - Google | $445 → $452+1.6% | Buy | +5.5% | Reiterated | 10.09.26on TipRanks 13:05 | — | |
| Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% | Bernstein | $488 | Buy | +13.9% | Reiterated | 09.09.26on TipRanks 06:35 | −0.8%next day +6.0% · 5 days +5.5% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | — | Hold | — | Reiterated | 20.08.26on TipRanks Aug 30 08:08 | +0.3%next day +0.7% · 5 days −0.4% | ↗ |
| Whit Mayo★★★★★★★★★★#3228 · hits 49% · avg +3.6% | Leerink Partners | $364 → $395+8.5% | Hold | −7.8% | Reiterated | 17.07.26on TipRanks 08:50 | +1.1%next day +2.6% · 5 days +1.8% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $404 | Hold | −5.7% | Assigned | 17.07.26on TipRanks Jul 16 07:26 | −3.9%next day +1.1% · 5 days +3.4% | ↗ |
| Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% | TD Cowen | $465 | Buy | +8.6% | Reiterated | 17.07.26on TipRanks Jul 14 05:50 | 0.0%next day −8.9% · 5 days −7.3% | ↗ |
| David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% | Jefferies | $391 → $450+15.1% | Buy | +5.1% | Reiterated | 16.07.26on TipRanks 08:50 | −3.9%next day +1.1% · 5 days +3.4% | ↗ |
| Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% | Robert W. Baird | $331 → $393+18.7% | Hold | −8.2% | Reiterated | 16.07.26on TipRanks 07:00 | −3.9%next day +1.1% · 5 days +3.4% | ↗ |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $475 | Buy | +10.9% | Reiterated | 16.07.26on TipRanks Jul 14 07:55 | 0.0%next day −8.9% · 5 days −7.3% | ↗ |
| Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% | Goldman Sachs | $370 → $395+6.8% | Hold | −7.8% | Reiterated | 15.07.26on TipRanks Jul 16 07:35 | −8.9%next day −3.9% · 5 days +0.7% | ↗ |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $439 → $424−3.4% | Hold | −1.0% | Reiterated | 15.07.26on TipRanks Jul 16 07:17 | −8.9%next day −3.9% · 5 days +0.7% | ↗ |
| Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% | Guggenheim | $399 → $455+14.0% | Buy | +6.2% | Reiterated | 15.07.26on TipRanks Jul 16 07:11 | −8.9%next day −3.9% · 5 days +0.7% | ↗ |
| Amit Daryanani★★★★★★★★★★#21 · hits 70% · avg +37.0% | Evercore ISI | — | Hold | — | Reiterated | 15.07.26on TipRanks 10:56 | −8.9%next day −3.9% · 5 days +0.7% | ↗ |
| Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% | Mizuho Securities | $465 → $470+1.1% | Buy | +9.7% | Reiterated | 13.07.26on TipRanks 08:15 | +2.9%next day 0.0% · 5 days −9.2% | ↗ |
| Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% | Cantor Fitzgerald | $400 → $450+12.5% | Buy | +5.1% | Reiterated | 07.07.26on TipRanks 07:16 | +3.1%next day −0.4% · 5 days +1.3% | ↗ |
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | $411 → $476+15.8% | Buy | +11.1% | Reiterated | 08.06.26on TipRanks 07:45 | +0.4%next day +1.8% · 5 days −5.6% | ↗ |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | $363 → $498+37.2% | Buy | +16.3% | Upgrade | 20.05.26on TipRanks 21:20 | −1.8%next day +0.9% · 5 days −1.0% | ↗ |
| Justin Lake★★★★★★★★★★#1616 · hits 68% · avg +12.7% | Wolfe Research | $425 | Buy | −0.8% | Upgrade | 07.01.26on TipRanks Jan 8 05:10 | −0.9%next day +2.2% · 5 days +1.6% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Elevance Health
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $446 at a price of $389 (+14.7%); now: $465 at $428 (+8.5%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 29 | 30 | 27 | 21 | 20 | 11 |
| Hold | 9 | 9 | 9 | 9 | 8 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 21.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $4.70 (from $4.55 to $4.99). Last quarter: $7.45.
Sales
Next quarter’s sales estimate — $49.3B (from $47.8B to $51.0B). Last quarter: $50.5B.
Best top-analyst consensus in the sector · Healthcare
About Elevance Health
- CEO: Gail Koziara Boudreaux
- Employees: 96,615
- 220 Virginia Avenue, Indianapolis, IN, 46204, US
- www.elevancehealth.com
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Data from the stock’s TipRanks forecast page, read 58 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗